Scarica l'app Stockscreener
16.77
1.21%
0.20
Precedente Chiudi:
$16.57
Aprire:
$16.55
Volume 24 ore:
739.53K
Relative Volume:
0.41
Capitalizzazione di mercato:
$1.14B
Reddito:
$2.66B
Utile/perdita netta:
$-1.21B
Rapporto P/E:
-0.9411
EPS:
-17.82
Flusso di cassa netto:
$-159.40M
1 W Prestazione:
+4.49%
1M Prestazione:
-4.25%
6M Prestazione:
-38.28%
1 anno Prestazione:
-27.15%
Intervallo 1D:
$16.00
$16.86
Intervallo di 1 settimana:
$16.00
$17.51
Portata 52W:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Nome
Quidelortho Corp
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
16.77 | 1.15B | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corp Borsa (QDEL) Ultime notizie
QuidelOrtho to Report Second Quarter 2026 Financial Results - marketscreener.com
QuidelOrtho Corp (QDEL) Institutional Confidence - TradingKey
QuidelOrtho Corp (QDEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
QuidelOrtho Corp (QDEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
QuidelOrtho Corp (QDEL) Balance Sheet - TradingKey
QDEL|QuidelOrtho Corp|Price:16.840| - TradingKey
QuidelOrtho Corp (QDEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
QuidelOrtho Corp (QDEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
QuidelOrtho Corp (QDEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QuidelOrtho Corporation (QDEL) to Release Q2 Financial Results S - GuruFocus
QuidelOrtho Results Will Arrive After Market Close Aug. 6 - Stock Titan
QuidelOrtho Corp (QDEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Reasons to Add QuidelOrtho Stock in Your Portfolio for Now - Yahoo Finance
Beyond Fentanyl: How the Drug Crisis Is Changing – Company Announcement - Financial Times
QuidelOrtho Corp (QDEL) Shares Fall 4.5% -- What GF Score of 43 Tells Investors - GuruFocus
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway - TradingView
QuidelOrtho (QDEL) 7th Annual Evercore ISI HealthCONx Conference Summary - Quartr
A Look at QuidelOrtho Corp (QDEL) After 4.8% Decline -- GF Value $37.34 vs Price $17.37 - GuruFocus
QuidelOrtho (QDEL) Files A Share Shelf, Is The Stock Still Cheap? - simplywall.st
QuidelOrtho reports inducement grant - Medical Buyer
QuidelOrtho Corp (QDEL) awards 356,555 restricted stock units to CFO - Stock Titan
QuidelOrtho CFO Micah Young Receives 356,555 Stock Units - Stock Titan
QuidelOrtho Corp (NASDAQ: QDEL) CFO reports zero stock ownership on Form 3 - Stock Titan
Frontier tech research, news & data - MLQ.ai
NEUBERGER BERMAN GROUP LLC Acquires Additional Shares in QuidelO - GuruFocus
QuidelOrtho taps former Masimo executive Micah Young as CFO - MSN
QuidelOrtho (QDEL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
QuidelOrtho Corp (QDEL) Shares Surge 4.8% -- What GF Score of 43 Tells Investors - GuruFocus
QuidelOrtho (QDEL) Is Down 5.1% After Broad Russell Growth Index RemovalWhat's Changed - simplywall.st
Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1 - Yahoo Finance
Neuberger Berman holds 3.53M shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho: Too Much Uncertainty Around Earnings Keeping Short-Interest Elevated (QDEL) - Seeking Alpha
Citi Maintains QuidelOrtho(QDEL.US) With Hold Rating, Raises Target Price to $18 - Moomoo
QuidelOrtho Corp highlights diagnostics portfolio as investors track Nasdaq listing - ad-hoc-news.de
QDEL stock eyes best day in over a year — point-of-care sale talks ignite rally - MSN
QuidelOrtho (QDEL) moves 32.2% higher: Will this strength last? - MSN
Jefferies downgrades QuidelOrtho (QDEL) - MSN
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Officer Hanson Bryan Michael - Moomoo
QDELQuidelOrtho Corp Earnings - Finviz
QuidelOrtho (QDEL) EVP Hanson converts 5,797 RSUs, 2,096 shares withheld for taxes - Stock Titan
QDEL Maintained by JP Morgan -- Price Target Raised to $12.00 - GuruFocus
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $12 - Moomoo
Is QuidelOrtho Corp (QDEL) a Bargain After 3.9% Drop? GF Value S - GuruFocus
QuidelOrtho Corp. Opens with 21.32% Gain Amid Ongoing Financial Challenges - MarketsMojo
Stocks making big moves yesterday: AppLovin, QuidelOrtho, Rocket Lab, Pinterest, and Zscaler - Barchart.com
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last? - Yahoo Finance
Does QuidelOrtho's (QDEL) Index Exit and New CFO Hint at a Shift in Growth Identity? - Yahoo Finance
QuidelOrtho (QDEL) stock trades up, here is why - MSN
Form 4 Quidel Corporation For: 29 June By Investing.com - Investing.com Canada
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J - Moomoo
QuidelOrtho (QDEL) director receives 15,532 restricted stock units as equity award - Stock Titan
Quidelortho Corp Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quidelortho Corp Azioni (QDEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):